CHRS icon

Coherus Oncology, Inc. Common Stock
CHRS

Overview Fund Activity

117 hedge funds and large institutions have $938M invested in Coherus Oncology, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 42 increasing their positions, 31 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
+6
Holders Change %
+5.41%
% of All Funds
2.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
42
Reduced
31
Closed
17
Calls
$1.18M
Puts
$358K
Net Calls
+$825K
Net Calls Change
+$1.13M

Top Buyers

1
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$64.7M
2
PHS
PFM Health Sciences
California
$12.9M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
$12.5M
4
TCIM
TIAA CREF Investment Management
New York
$28.4M
5
Millennium Management
Millennium Management
New York
$10.2M

Top Sellers

1
Deutsche Bank
Deutsche Bank
Germany
$13.6M
2
CC
Carlson Capital
Texas
$6.76M
3
Fidelity Investments
Fidelity Investments
Massachusetts
$56.3M
4
State Street
State Street
Massachusetts
$30.4M
5
RCMNY
Rubric Capital Management (New York)
New York
$36M
Name Holding Trade Value Shares
Change 		Shares
Change %
JG
126
Jefferies Group
New York
– -$91K -10,060 Closed
RBFC
127
Roman Butler Fullerton & Co
Missouri
– -$122K -10,000 Closed
Federated Hermes
128
Federated Hermes
Pennsylvania
– -$12K -1,348 Closed
QT
129
Quantamental Technologies
New York
– -$12K -1,286 Closed
AIM
130
Assured Investment Management
New York
– -$11K -1,219 Closed
Bank of Montreal
131
Bank of Montreal
Ontario, Canada
– -$7K -737 Closed
Group One Trading
132
Group One Trading
Illinois
– -$1K -140 Closed
2 3 4 5
6